EKSO

#4426
Ekso Bionics Holdings, Inc. Common Stock
11.3700 USD
+1.70%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
11.3700
11.3700
Yıllık Aralık
7.8900
13.5000
Günlük Değişim
+1.70%
Aylık Değişim
+13.59%
6 Aylık Değişim
-9.19%
Yıllık Değişim
-9.19%
Önceki Kapanış
11.1800
Açılış
11.3700
Düşük
11.3700
High
11.3700
Hacim
1
Tam grafiği aç

Financials

Genel Bakış Tablolar İstatistikler
Çeyreklik Yıllık
  • Market Capitalization 40.5156 M
  • Employee 55
  • Founded 2005
  • CEO Scott Davis
  • Website www.eksobionics.com
  • Headquarter Nevada, United States
  • FIGI BBG002Z0NKK4
  • Industry Tıbbi Aletler ve Malzemeler
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.76
Fiyat/satışlar oranı
1.64

Ekso Bionics Holdings Inc

Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community.

Haberler